RheumaGen

RheumaGen is a private biotechnology company dedicated to developing a new class of therapies to treat major autoimmune diseases. RheumaGen focuses on editing human leukocyte antigen (HLA) or "immune genes" to develop one-time curative cell and gene therapies.